Chemical composition, antioxidant and anticholinesterase activity of Melissa officinalis

Industrial Crops and Products

Volumn 53, Issue , 2014, Pages 34-45

  Pereira, Romaiana Picada ^a   Boligon, Aline Augusti ^b   Appel, André Storti ^b   Fachinetto, Roselei ^b   Ceron, Carla Speroni ^c   Tanus Santos, José Eduardo ^c   Athayde, Margareth Linde ^b   Rocha, João Batista Teixeira ^b,d  

^a STATE UNIVERSITY OF PONTA GROSSA   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d ABDUS SALAM INTERNATIONAL CENTRE FOR THEORETICAL PHYSICS   (Italy)

Author keywords

Alzheimer's disease; Gallic acid; Melissa officinalis; Oxidative stress; Quercetin

Indexed keywords

ANTIOXIDANTS; ENZYME INHIBITION; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS;

ALZHEIMER'S DISEASE; ANTICHOLINESTERASE ACTIVITIES; CENTRAL NERVOUS SYSTEMS; GALLIC ACIDS; MATRIX METALLOPROTEINASE-2; MELISSA OFFICINALIS; NUCLEAR MAGNETIC RESONANCE(NMR); QUERCETIN;

PLANT EXTRACTS;

ANTIOXIDANT; CHEMICAL COMPOSITION; DISEASE CONTROL; DISEASE INCIDENCE; ENZYME ACTIVITY; EXPERIMENTAL STUDY; NERVOUS SYSTEM; PLANT COMMUNITY;

EID: 84984577410     PISSN: 09266690     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.indcrop.2013.12.007     Document Type: Article

References (62)

1. Adams R.P. Identifi cation of Essential Oil Components by Gas Chromatography/quadrupole Mass Spectroscopy 2001, Allured, Carol Stream, IL.
2. Akhondzadeh S., Noroozian M., Mohammadi M., Ohadinia S., Jamshidi A.H., Khani M. Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized, placebo controlled trials. J. Neurol. Neurosurg. Psychiatry 2003, 74:863-866.
3. Aldini G., Yeum K., Carnini M., Krinsky N.I., Russell R.M. (-)-Epigallocatechin-(3)-gallate prevents oxidative damage in boththe aqueous and lipid compartments of human plasma. Biochem. Biophys. Res. Commun. 2003, 302:409-414.
4. Aliev G., Obrenovich M.E., Reddy V.P., Shenk J.C., Moreira P.I., Nunomura A., Zhu X., Smith M.A., Perry G. Antioxidant therapy in Alzheimer's disease: theory and practice. Mini Rev. Med. Chem. 2008, 8:1395-1406.
5. Aliev G., Palaciosa H.H., Walrafen B., Lipsitt A.E., Obrenovich M.E., Morales L. Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease. Int. J. Biochem. Cell Biol. 2009, 41:1989-2004.
6. Aruoma O.I. Free radicals, oxidative stress, and antioxidants in human health and disease. J. Am. Oil Chem. Soc. 1998, 75:671-683.
7. Boligon A.A., Pereira R.P., Feltrin A.C., Machado M.M., Janovik V., Rocha J.B.T., Athayde M.L. Antioxidant activities of flavonol derivatives from the leaves and stem bark of Scutia buxifolia Reiss. Bioresour. Technol. 2009, 100:6592-6598.
8. Boligon A.A., Feltrin A.C., Machado M.M., Janovik V., Athayde M.L. HPLC analysis and phytoconstituents isolated from ethyl acetate fraction of Scutia buxifolia Reiss leaves. Lat. Am. J. Pharm. 2009, 28:121-124.
9. Brand W.W., Cuvelier M.C., Berset C. Use of a free-radical method to evaluate antioxidant activity. LWT 1995, 28:25-30.
10. Cao J., Sato H., Takino T., Seiki M. The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation. J. Biol. Chem. 1995, 270:801-805.
11. Castro M.M., Rizzi E., Rodrigues G.J., Ceron C.S., Bendhack L.M., Gerlach R.F., Tanus-Santos J.E. Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension. Free Radic. Biol. Med. 2009, 46:1298-1307.
12. Ceron C.S., Castro M.M., Rizzi E., Montenegro M.F., Fontana V., Salgado M.C.O., Gerlach R.F., Tanus-Santos J.E. Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertensionbph. Br. J. Pharmacol. 2010, 160:77-87.
13. Coyle J.T., Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993, 262:689-695.
14. Choi C.W., Kim S.C., Hwang S.S., Choi B.K., Ahn H.J., Lee M.Y., Paerk S.H., Kim S.K. Antioxidant activity and free radical scavenging capacity between Korean medicinal plants and flavonoids by assay-guided comparison. Plant Sci. 2002, 153:1161-1168.
15. Dastmalchi K., Dorman H.J.D., Vuorela H., Hiltunen R. Plants as potential sources for drug development against Alzheimer's disease. Int. J. Biomed. Pharm. Sci. 2007, 1:83-104.
16. Dastmalchi K., Ollilainen V., Lackman P., Gennäs G.B., Dorman H.J.D., Järvinen P.P., Yli-Kauhaluoma J., Hiltunen R. Acetylcholinesterase inhibitory guided fractionation of Melissa officinalis L. Bioorg. Med. Chem. 2009, 17:867-871.
17. De-Eknankul W., Potduang P. Biosynthesis of ß-sitosterol and stigmasterol in Croton sublyratus proceeds via a mixed origin of isoprene units. Phytochemistry 2003, 62:389-398.
18. Demeule M., Brossard M., Page M., Gingras D., Beliveau R. Matrix metalloproteinase inhibition by green tea catechins. Biochim. Biophys. Acta 2000, 1478:51-60.
19. dos Santos-Neto L.L., de Vilhena Toledo M.A., Medeiros-Souza P., de Souza G.A. The use of herbal medicine in Alzheimer's disease--a systematic review. Evid Based Complement Alternat. Med. 2006, 3:441-445.
20. Ellman G.L., Courtney D.K., Andres V., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7:88-95.
21. Ferreira A., Proenc C., Serralheiro M.L.M., Araújo M.E.M. The in vitro screening for acetylcholinesterase inhibition and antioxidant activity of medicinal plants from Portugal. J. Ethnopharmacol. 2006, 108:31-37.
22. Ferretti G., Bacchetti T., Masciangelo S., Bicchiega V. Effect of phytosterols on copper lipid peroxidation of human low-density lipoproteins. Nutrition 2010, 26:296-304.
23. 1H NMR chemical shift assignment of the skeleton and side-chain resonances of stigmasterol, a phytosterol derivative. Steroids 2004, 69:43-50.
24. Fossen T., Pedersen A.T., Andersen O.M. Flavonoids from red onion (Allium cepa). Phytochemistry 1998, 47:281-285.
25. Finkel T., Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature 2000, 408:239-247.
26. Francis P.T., Palmer A.M., Snape M., Wilcock G.K. The cholinergic hypothesis of Alzheimer's disease: a review of progress. J. Neurol. Neurosurg. Psychiatry 1999, 66:137-147.
27. Fu X., Parks W.C., Heinecke J.W. Activation and silencing of matrix metalloproteinases. Semin. Cell Dev. Biol. 2008, 19:2-13.
28. Garcia-Alloza M., Prada C., Lattarulo C., Fine S., Borrelli L.A., Betensky R., Greenberg S.M., Frosch M.P., Bacskai B.J. Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice. J. Neurochem. 2009, 109:1636-1647.
29. Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine 1999, Oxford University Press, Oxford.
30. Haorah J., Ramirez S.H., Schall K., Smith D., Pandya R., Persidsky Y. Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction. J. Neurochem. 2007, 101:566-576.
31. Hatano T., Edmatsu R., Hiramatsu M., Mori A., Fujita Y., Yasuhara T., Yoshida T., Okuda T. Effects of the interaction of tannins with coexisting substances. VI: Effect of tannins and related polyphenols on superoxide anion radicals and on DPPH. Chem. Pharm. Bull. 1989, 37:2016-2021.
32. Jayaprakasha G.K., Mandadi K.K., Poulose S.M., Jadegoud Y., Nagana Gowdab G.A., Patila B.S. Inhibition of colon cancer cell growth and antioxidant activity of bioactive compounds from Poncirus trifoliata (L.) Raf. Bioorg. Med. Chem. 2007, 15:4923-4932.
33. Jung S.S., Zhang W., Van Nostrand W.E. Pathogenic A beta induces the expression and activation of matrix metalloproteinase-2 in human cerebrovascular smooth muscle cells. J. Neurochem. 2003, 85:1208-1215.
34. Kennedy D.O., Scholey A.B., Tildesley N.T., Perry E.K., Wesnes K.A. Modulation of mood and cognitive performance following acute administration of Melissa officinalis lemon balm. Pharmacol. Biochem. Behav. 2002, 72:953-964.
35. Kennedy D.O., Little W., Scholey A.B. Attenuation of laboratory-induced stress in humans after acute administration of Melissa officinalis (Lemon Balm). Psychosom. Med. 2004, 66:607-613.
36. Kennedy D.O., Little W., Haskell C.F., Scholey A.B. Anxiolytic effects of a combination of Melissa officinalis and Valeriana officinalis during laboratory induced stress. Phytother. Res. 2006, 20:96-102.
37. Liu X., Cui C., Zhao M., Wang J., Luo W., Yang B., Jiang Y. Identification of phenolics in the fruit of emblica (Phyllanthus emblica L.) and their antioxidant activities. Food Chem. 2008, 109:909-915.
38. Misra H.P., Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem. 1972, 247:3170-3175.
39. Nie K., Yu J.C., Fu Y., Cheng H.Y., Chen F.Y., Qu Y., Han J.X. Age-related decrease in constructive activation of Akt/PKB in SAMP10 hippocampus. Biochem. Biophys. Res. Commun. 2009, 378:103-107.
40. Oboh G., Rocha J.B.T. Polyphenols in red pepper [Capsicum annuum var. aviculare (Tepin)] and their protective effect on some pro-oxidants induced lipid peroxidation in brain and liver. Eur. Food Res. Technol. 2007, 225:239-247.
41. Ohkawa H., Ohishi H., Yagi K. Assay for lipid peroxide in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95:351-358.
42. Park J.W., Hong J.S., Lee K.S., Kim H.Y., Lee J.J., Lee S.R. Green tea polyphenol (-)-epigallocatechin gallate reduces matrix metalloproteinase-9 activity following transient focal cerebral ischemia. J. Nutr. Biochem. 2010, 21:1038-1044.
43. Pereira R.P., Fachinetto R., Prestes A.L., Puntel R.L., Silva G.N.S., Heinzmann B.M., Boschetti T.K., Athayde M.L., Burger M.E., Morel A.F., Morsch V.M., Rocha J.B.T. Antioxidant effects of different extracts from Melissa officinalis, Matricaria recutita and Cymbopogon citratus. Neurochem. Res. 2009, 34:973-983.
44. Perry E.K., Pickering A.T., Wang W.W., Houghton P.J., Perry N.S. Medicinal plants and Alzheimer's disease: from ethnobotany to phytotherapy. J. Pharm. Pharmacol. 1999, 51:527-534.
45. Perry E.K. The cholinergic hypothesis, ten years on. Br. Med. Bull. 1986, 42:63-69.
46. Puntel R.L., Roos D.H., Grotto D., Garcia S.C., Nogueira C.W., Rocha J.B. Antioxidant properties of Krebs cycle intermediates against malonate pro-oxidant activity in vitro: a comparative study using the colorimetric method and HPLC analysis to determine malondialdehyde in rat brain homogenates. Life Sci. 2007, 81:51-62.
47. Rocha J.B.T., Emmanuelli T., Pereira M.E. Effects of early undernutrition on kinetic parameters of brain acetylcholinesterase from adult rats. Acta Neurobiol. Exp. 1993, 53:431-437.
48. Sabir S.M., Ahmad S.D., Hamid A., Khan M.Q., Athayde M.L., Santos D.B., Boligon A.A., Rocha J.B.T. Antioxidant and hepatoprotective activity of ethanolic extract of leaves of Solidago microglossa containing polyphenolic compounds. Food Chem. 2012, 741-747.
49. Sen T., Moulik S., Dutta A., Choudhury P.R., Banerji A., Das S., Roy M., Chatterjee A. Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7. Life Sci. 2009, 84:194-204.
50. Shahrzad S., Aoyagi K., Winter A., Koyama A., Bitsch I. Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humans. J. Nutr. 2001, 131:1207-1210.
51. Singh M., Arseneault M., Sanderson T., Murthy V., Ramassamy C. Challenges for research on polyphenols from foods in Alzheimer's disease: bioavailability, metabolism, and cellular and molecular mechanisms. J. Agric. Food Chem. 2008, 56:4855-4873.
52. Slimestad R. Flavonoids in buds and young needles of Picea, Pinus and Abies. Biochem. Syst. Ecol. 2003, 31:1247-1255.
53. Stopa E.G., Butala P., Salloway S., Johanson C.E., Gonzalez L., Tavares R., Hovanesian V., Hulette C.M., Vitek M.P., Cohen R.A. Cerebral cortical arteriolar angiopathy, vascular beta-amyloid, smooth muscle actin, Braak stage, and APOE genotype. Stroke 2008, 39:814-821.
54. Sun A.Y., Wang Q., Simonyi A., Sun G.Y. Resveratrol as a therapeutic agent for neurodegenerative diseases. Mol. Neurobiol. 2010, 41:375-383.
55. Van Marum R.J. Current and future therapy in Alzheimer's disease. Fundam. Clin. Pharmacol. 2008, 22:265-274.
56. Van Wart H.E., Birkedal-Hansen H. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sci. U.S.A. 1990, 87:5578-5582.
57. Vinson J.A., Dabbagh Y.A., Serry M.M., Jang J. Plant flavonoids, especially tea flavonoids, are powerful antioxidants using an in vitro oxidation model for heart disease. J. Agric. Food Chem. 1995, 43:2800-2802.
58. Wagner C., Fachinetto R., Dalla Corte C.L., Brito V.B., Severo D., Dias G.O.C., Morel A.F., Nogueira C.W., Rocha J.B.T. Quercitrin, a glycoside form of quercetin, prevents lipid peroxidation in vitro. Brain Res. 2006, 1107:192-198.
59. Wheatley D. Medicinal plants for insomnia: a review of their pharmacology, efficacy and tolerability. J. Psychopharmacol. 2005, 19:414-421.
60. Wiseman S.A., Balentine D.A., Frei B. Antioxidants in tea. Crit. Rev. Food Sci. Nutr. 1997, 37:705-718.
61. Yasuda T., Inaba A., Ohmori M., Endo T., Kubo S., Ohsawa K. Urinary metabolites of gallic acid in rats and their radical scavenging effect on DPPH. J. Nat. Prod. 2000, 63:1444-1446.
62. Zhang-Nunes S.X., Maat-Schieman M.L., van Duinen S.G., Roos R.A., Frosch M.P., Greenberg S.M. The cerebral beta-amyloid angiopathies: hereditary and sporadic. Brain Pathol. 2006, 16:30-39.